carmustine and arsenic trioxide

carmustine has been researched along with arsenic trioxide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meng, H; Qian, W; Shao, K; Yang, C; Yang, X; Ye, X; Zhou, Y1
Chang, JY; Chen, KL; Chen, LT; Chen, SN; Cheng, YT; Kuo, CC; Liu, JF; Liu, TW; Pan, WY; Shiah, HS; Wu, CM; Yang, YN1

Other Studies

2 other study(ies) available for carmustine and arsenic trioxide

ArticleYear
Refractory multiple myeloma treated with homoharringtonine: report of two cases.
    Annals of hematology, 2007, Volume: 86, Issue:12

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Harringtonines; Homoharringtonine; Humans; Male; Melphalan; Multiple Myeloma; Oxides; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Vincristine; Vindesine

2007
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors.
    Free radical biology & medicine, 2011, Dec-15, Volume: 51, Issue:12

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Autophagy; Carmustine; Cell Death; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Glutathione; Glutathione Reductase; Humans; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Structure-Activity Relationship; Tumor Cells, Cultured

2011